Rifampicin in the treatment of psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 1, 2009, Pages 93-95

  Tsankov, N ^a   Grozdev, I ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; RIFAMPICIN;

ADOLESCENT; ADULT; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RIFAMPIN; TREATMENT OUTCOME;

EID: 57649234618     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02721.x     Document Type: Letter

References (10)

1. Paunescu E. In vivo and in vitro suppression of humoral and cellular response by rifampicin. Nature 1970 229 : 1188 1189.
2. Nilsson BS. Rifampicin: an immunosuppressant? Lancet 1971 2 : 374.
3. Dajani BM, Canadi MS, Thompson JS, Kasisk JE. Rifampicin: an immunosuppressant? Lancet 1972 2 : 1904.
4. Tsankov N, Angelova I. Rifampin in dermatology. Clin Dermatol 2003 21 : 50 55.
5. Mlambo G, Sigola LB. Rifampicin and dexamethasone have similar effects on macrophage phagicytosis of zymosan, but differ in their effects on nitrite and TNF-alpha production. Int Immunopharmacol 2003 3 : 513 522.
6. Ziglam HM, Daniels I, Finch RG. Immunomodulating activity of rifampicin. J Chemother 2004 16 : 357 361.
7. Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med 1998 4 : 92 96.
8. Tsankov N, Krasteva M. On rifampin treatment of psoriasis. J Am Acad Dermatol 1993 29 : 1057 (letter).
9. Kzandjieva J, Kamarashev J, Hinkov G, Tsankov N. Rifampicin und psoriasis. Akt Dermatol 1997 23 : 78 81.
10. Tsankov N, Grozdev I, Kazandjieva J. Old drug - new indication. Rifampicin in psoriasis. J Dermatol Treat 2006 17 : 18 23.